SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-15-081813
Filing Date
2015-11-23
Accepted
2015-11-23 17:14:14
Documents
1
Period of Report
2015-11-17

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3973
  Complete submission text file 0001209191-15-081813.txt   5511
Mailing Address 615 ARAPEEN DRIVE SUITE 102 SALT LAKE CITY UT 84108
Business Address 615 ARAPEEN DRIVE SUITE 102 SALT LAKE CITY UT 84108 (801) 582-5400
Q Therapeutics, Inc. (Issuer) CIK: 0001366541 (see all company filings)

IRS No.: 203708500 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 110 WEST TAYLOR STREET SAN JOSE CA 95110
Business Address
Green David A (Reporting) CIK: 0001372822 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-52062 | Film No.: 151250442